BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Pfizer COVID Vaccine Contributor Saama Lands $430 Million Investment

  Saama Technologies secured a $430 million investment from the Carlyle Group and venture funds from some of the pharmaceutical industry’s biggest companies.

  October 21, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  AstraZeneca Cancer Trial Hit with Clinical Hold Following Cardiac Issues

  An experimental AstraZeneca cancer drug trial has been placed on hold due to safety concerns. This news comes two years after Amgen was also forced to pause a study of a drug within the same class.

  October 21, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  Three Studies Validate Effectiveness of Pfizer-BioNTech Vaccine, Booster

  The Pfizer-BioNTech mRNA COVID-19 vaccine is reportedly the top vaccine used globally. Here’s a look at today’s highlights.

  October 21, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Intellia’s Milestone In Vivo CRISPR Therapy Granted FDA Orphan Drug Designation

  The experimental drug, NTLA-2001, is being developed for the treatment of transthyretin (ATTR) amyloidosis.

  October 21, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  BioMidwest

  Research Roundup: Regrowing Nerve Cells in Spinal Cord Injuries and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  October 21, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Drug Supply Chain Security Act Challenges Pharma to E Track Individual Items

  The upcoming changes will be less disruptive but will have far-reaching consequences throughout the pharmaceutical supply chain.

  October 21, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  FDA

  FDA Signs Off on Moderna, J&J Boosters and Mixed Doses

  The U.S. FDA approved the use of Moderna’s and Janssen’s COVID-19 vaccines as a booster dose after their primary versions are completed.

  October 21, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  BioSpace Movers & Shakers, Oct. 22

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  October 21, 2021

   · 

  10 min read

   · 

  Alex Keown
• 

  Biotech Bay

  ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs

  ReCode is aiming to advance its lead candidates for cystic fibrosis and primary ciliary dyskinesia (PCD).

  October 21, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Vaccine Manufacturers Practicing for Worse COVID-19 Variants to Emerge

  Winter is quickly approaching in the U.S. Vaccine makers aren’t taking a wait-and-see approach but actively preparing for what may come next.

  October 21, 2021

   · 

  3 min read

   · 

  Kate Goodwin